World Health Organization Issues Concern Over Acute Lack of Obesity Medications
Less than a tenth of people who could benefit from obesity jabs like Wegovy have access to them, states the WHO as it issues its initial advice on the therapies.
Considering in excess of 1,000,000,000 people worldwide currently obese, it is advocating for increased and just availability to these injectable treatments.
Per forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 without intervention.
"Our new guidelines acknowledges that excess weight is a long-term condition that can be managed with holistic and ongoing support," stated its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and logistical bottlenecks are significant obstacles to broad availability to the jabs that can help people shift substantial body mass, says the agency.
GLP-1 Therapy Supply Crisis
Even under the present most favorable outlook, the production of these medications might only reach approximately 100 million people – less than 10% of the global need, per the WHO.
The guideline urges governments and firms to expand availability, by strategies like voluntary licensing.
Exclusive production rights on the active ingredient – the core ingredient of Novo Nordisk's Wegovy – is scheduled to end in several nations in 2026.
The Way Weight-Loss Injections Work
These medications imitate a biological compound to delay gastric emptying, suppress the appetite and enhance satiety so people eat less.
Individuals commonly start to lose weight in the initial weeks of beginning the once-weekly jabs.
Research indicates patients may put most of the weight back on a year later of discontinuing the drug, because their normal food cravings come back.
Being overweight or obese elevates your likelihood for experiencing medical conditions, such as type 2 diabetes, cardiovascular issues, brain attack, and some cancers.
Obesity impacts individuals in every country and was associated with 3.7 million deaths worldwide in 2024, per the health agency.
